4.6 Article

Intranasal oxygen reverses hypoxaemia in immobilised free-ranging capybaras (Hydrochoerus hydrochaeris)

Journal

PLOS ONE
Volume 16, Issue 11, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0260441

Keywords

-

Funding

  1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2016/21121-9]

Ask authors/readers for more resources

The study found that different chemical restraint protocols did not affect blood variables in capybaras, but could lead to hypoxaemia. Nasal oxygen supplementation at 2 L/min after 30 min improved hypoxaemia, with 5 L/min being more efficient in treating it.
Capybara (Hydrochoerus hydrochaeris) is the main host of tick-borne pathogens causing Brazilian spotted fever; therefore, controlling its population is essential, and this may require chemical restraint. We assessed the impact of chemical restraint protocols on the partial pressure of arterial oxygen (PaO2) and other blood variables in 36 capybaras and the effect of different flows of nasal oxygen (O-2) supplementation. The capybaras were hand-injected with dexmedetomidine (5 mu g/kg) and midazolam (0.1 mg/kg) and butorphanol (0.2 mg/kg) (DMB, n = 18) or methadone (0.1 mg/kg) (DMM, n = 18). One-third of the animals were maintained in ambient air throughout the procedure, and one-third were administered intranasal 2 L/min O-2 after 30 min whereas the other third were administered 5 L/min O-2. Arterial blood gases, acid-base status, and electrolytes were assessed 30 and 60 min after drug injection. The DMB and DMM groups did not vary based on any of the evaluated variables. All animals developed hypoxaemia (PaO2 44 [30; 73] mmHg, SaO(2) 81 [62; 93] %) 30 min before O-2 supplementation. Intranasal O-2 at 2 L/min improved PaO2 (63 [49; 97] mmHg and SaO(2) [92 [85; 98] %), but 9 of 12 capybaras remained hypoxaemic. A higher O-2 flow of 5 L/min was efficient in treating hypoxaemia (PaO2 188 [146; 414] mmHg, SaO(2) 100 [99; 100] %) in all the 12 animals that received it. Both drug protocols induced hypoxaemia, which could be treated with intranasal oxygen supplementation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available